"Nationally recognized for our kidney, liver and pancreas transplant program, we are proud to serve transplant recipients throughout the country. Our living kidney donor program is unparalleled. We are committed to every patient, every day. At Methodist Hospital Specialty and Transplant, you're family."

During the past decade, Methodist Healthcare System of San Antonio/Texas Transplant Institute conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Methodist Healthcare System of San Antonio/Texas Transplant Institute" #1 sponsor was "Center for International Blood and Marrow Transplant Research" with 2 trials, followed by "Conatus Pharmaceuticals Inc." with 1 trials sponsored, "Harvard Pilgrim Health Care" with 1 trials sponsored, "Johns Hopkins University" with 1 trials sponsored and "University of California, Irvine" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Methodist Healthcare System of San Antonio/Texas Transplant Institute" #1 collaborator was "Centers for Disease Control and Prevention" with 2 trials as a collaborator, "Rush University" with 2 trials as a collaborator, "Harvard Medical School (HMS and HSDM)" with 1 trials as a collaborator, "Harvard Pilgrim Health Care" with 1 trials as a collaborator and "Hospital Corporation of America" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Methodist Healthcare System of San Antonio/Texas Transplant Institute" are "Acute Lymphoblastic Leukemia (ALL)" (1 trials), "Acute Myelogenous Leukemia (AML or ANLL)" (1 trials), "Autoimmune Diseases" (1 trials), "Chronic Myelogenous Leukemia (CML)" (1 trials) and "Decompensated Cirrhosis" (1 trials). Many other conditions were trialed in "Methodist Healthcare System of San Antonio/Texas Transplant Institute" in a lesser frequency.

Most popular intervention types in "Methodist Healthcare System of San Antonio/Texas Transplant Institute" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs)" (1 trials), "Arm 1. Routine Care (Mupirocin/CHG)" (1 trials), "Arm 2. Iodophor/CHG Decolonization" (1 trials), "Arm 2: Decolonization" (1 trials) and "Emricasan (25 mg)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Methodist Healthcare System of San Antonio/Texas Transplant Institute" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Methodist Healthcare System of San Antonio/Texas Transplant Institute". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Methodist Healthcare System of San Antonio/Texas Transplant Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Methodist Healthcare System of San Antonio/Texas Transplant Institute, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".